Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06453720

Predicting IBD Treatment Outcomes With Gut Microbiome Analysis

Sponsor: University of British Columbia

View on ClinicalTrials.gov

Summary

The goal of this prospective observational study is to determine if specific microbiome signatures can predict therapeutic responses in adult patients with Crohn's disease (CD), a form of inflammatory bowel disease (IBD), living in British Columbia, Canada. The main questions this study seeks to answer are: 1. Can microbiome signatures across different sample types (fecal, intestinal washings, and intestinal epithelial biopsies) predict response to therapy in CD? 2. How do microbiome profiles differ between active and quiescent CD and non-IBD controls? Researchers will compare microbiome signatures in patients with active and inactive CD as well as non-IBD controls to see if there are any microbial signatures that predict response to therapy. Participants will: 1. Provide fecal and blood samples. 2. Undergo intestinal washings and intestinal epithelial biopsy specimens taken during routine colonoscopy. 3. Participate in a longitudinal follow-up over 12 months to monitor clinical, biochemical, and endoscopic responses to therapy.

Official title: Optimizing Patient Treatment Involving Microbiome Integration for Specialized Therapeutics

Key Details

Gender

All

Age Range

19 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2024-08-01

Completion Date

2027-04-01

Last Updated

2026-01-20

Healthy Volunteers

Yes

Interventions

PROCEDURE

Colonoscopy

A colonoscopy will be performed as part of routine clinical care for all participants, with the study not requiring any additional scheduling commitments outside of routine care.

Locations (1)

GI Research Institute

Vancouver, British Columbia, Canada